Fosaprepitant Dimeglumine 0.15?g

Fosaprepitant Dimeglumine 0.15?g

$1.00

Fosaprepitant Dimeglumine Injection (brand: Mengsha®) is a neurokinin?1 (NK?) receptor antagonist developed by Shandong Luoxin Pharmaceutical Co., Ltd. (NMPA No.?H20223351; Code?86904141003343). Supplied as 0.15?g per vial of lyophilized powder (1 vial/box). This intravenous prodrug converts to aprepitant, widely used in research to prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV). Strictly for laboratory research?Please consult the staff for other purposes?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Fosaprepitant Dimeglumine Product Specifications

Attribute Details
Product Name Fosaprepitant Dimeglumine Injection (Mengsha®)
Strength 0.15?g fosaprepitant per vial
Quantity 1 vial per box
Dosage Form Lyophilized powder for injection
Approval Number China NMPA H20223351
Product Code 86904141003343
Manufacturer Shandong Luoxin Pharmaceutical Co., Ltd.
CAS Number 172673?20?0 (fosaprepitant) en.wikipedia.orgzh.wikipedia.org+1en.wikipedia.org+1
Molecular Formula C??H??F?N?O?P?·?dimeglumine
Mechanism of Action Intravenous prodrug of aprepitant ? NK? receptor antagonist
Intended Use Laboratory research only — Not for clinical or veterinary use

Fosaprepitant Dimeglumine Mechanism of Action

Fosaprepitant is a phosphorylated prodrug converted in vivo into aprepitant, a potent NK? receptor antagonist. It inhibits substance P binding in the brain’s vomiting center, thus preventing both acute and delayed CINV.


 Research & Pharmacology Context

  • Intravenous fosaprepitant is bioequivalent to oral aprepitant, offering research flexibility when oral dosing is unsuitable

  • Studies show its effectiveness in combination with 5-HT? antagonists and corticosteroids to prevent both acute and delayed emesis in high-emetogenic chemotherapy (HEC)

  • Conversion to aprepitant occurs rapidly—levels rising within 30 minutes post-infusion.

  • Dimeglumine form included in China’s 2019 National Encouraged Generic Drug List .


 Research Applications

  • CINV prevention studies in preclinical chemotherapy models

  • NK? receptor antagonism research: comparing IV vs oral administrations

  • Combination protocols with 5-HT? antagonists and steroids

  • Dose-timing studies of acute/delayed emesis models


?? Research?Use Only Disclaimer

This product is supplied strictly for laboratory research and development use. Not intended for clinical, diagnostic, therapeutic, or veterinary applications.

其他信息

重量 1.1 公斤
尺寸 18 × 16 × 18 厘米

评价

目前还没有评价

成为第一个“Fosaprepitant Dimeglumine 0.15?g” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

EMI Options

Select at least 2 products
to compare